Part B Drugs – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Part B Drugs

Part B Drugs

Showing 1 - 10 out of 191

Jul 26, 2023 / Data Book

July 2023 Data Book: Health Care Spending and the Medicare Program

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2023 / Press Releases

MedPAC releases June 2023 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Jun 15, 2023 / Chapters

Executive summary (June 2023 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2023 / Reports

June 2023 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jan 13, 2023 / Presentations

Addressing high prices of drugs covered under Medicare Part B

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Quality

Oct 20, 2022 / Payment Basics

Part B drugs payment systems

Research Areas:

Drugs, Devices, and Tests

Sep 12, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on the payment systems for hospital outpatient departments and ambulatory surgical centers for 2023

Research Areas:

Ambulatory Care Settings, Drugs, Devices, and Tests, Hospitals, Quality, Regional Issues

Sep 02, 2022 / Comment Letters

MedPAC comment on CMS’s proposed rule on CY 2023 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Physicians And Other Health Professionals, Quality

Sep 01, 2022 / Transcripts

September 1-2, 2022 meeting transcript

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing, Physicians And Other Health Professionals, Private Plans, Quality